Pulse Biosciences, Inc. ( PLSE) - Key Metrics
PLSE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.36 | -$0.27 | -$0.27 |
| 2026Q1 | $0.01 | -$0.27 | -$0.22 | -$0.22 |
| 2025Q4 | $0 | -$0.26 | -$0.22 | -$0.22 |
| 2025Q3 | $0 | -$0.29 | -$0.19 | -$0.19 |
| 2025Q2 | $0 | -$0.28 | -$0.19 | -$0.19 |
PLSE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -19.26 |
| 2026Q1 | 0% | -20.76 |
| 2025Q4 | 0% | -13.20 |
| 2025Q3 | 0% | -15.26 |
| 2025Q2 | 0% | -13.47 |
PLSE
Price: $44.43
52 week price:
Earnings Per Share: -1.17 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 25600
Ebitda: -14.3 millionMarket Capitalization: 3.3 billion